Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 2/20 | 0.36 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8645671 | 1.00 | DPP9 (0.42) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL8580792 | 0.83 | KDM4E (0.51) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL8582274 | 0.83 | KDM4E (0.51) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL9315974 | 0.79 | GSR (0.48) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL9315967 | 0.79 | GSR (0.48) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL31229954 | 0.77 | ALOX5 (0.47) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL27475290 | 0.77 | GSK3B (0.50) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL31411149 | 0.77 | GSK3B (0.50) | DPP9DPP8DPP7MMP2GSR | |
| SCHEMBL28841500 | 0.74 | TDP1 (0.43) | GSRNAPRT | |
| Lysine SCHEMBL28641263 | 0.73 | LMNA (0.59) | DPP9DPP8DPP7MMP2GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5821065-A | INCUBATING BODY FLUID SAMPLE WITH ANTIBODY WHICH SPECIFICALLY BINDS WITH SPECIFIED AMINO ACID SEQUENCE, DETERMINING COLLAGEN DEGRADATION PRODUCTS BOUND TO ANTIBODY | BOEHRINGER MANNHEIM GMBH (DE) | 1998-10-13 | — | — | US | disclosed |